There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
The former COO of franchisee DMD Ventures accused the company’s co-founders of using corporate funds to pay for lavish ...
The former chief operating officer of several high-volume Twin Peaks restaurants is suing his business partners, alleging ...
Dr. Mitzi Morris, a distinguished dentist in Roswell, GA, has been honored as a 2025 Top Patient Rated Dentist by Find Local ...
Deputy Managing Director of EXIM Bank, Tarun Sharma, highlights the importance of the manufacturing sector in achieving India ...
2d
GlobalData on MSNCumberland Pharmaceuticals reports data from trial of ifetroban for DMDHigh-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.
Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...
Tinubu has congratulated ARISE NEWS DMD Bayo Awosemo on his 70th birthday, commending him for enhancing Nigeria’s image ...
While the last decade has brought considerable progress for patients with DMD, substantial unmet need remains. Several ...
Pharmaceuticals announced positive top-line results from its Phase 2 FIGHT DMD trial. The study evaluated ifetroban, a novel ...
The gene therapy improved motor functions in children with Duchenne muscular dystrophy two years after treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results